Atlanta, United States
InpharmD is a promising startup founded in 2018 that operates at the intersection of AI, Health Care, and Machine Learning. With its slogan, "Clinicians ask questions. We provide customized, evidence-based, digital responses," it captures its core mission succinctly.
The company is leveraging advanced technologies to enhance healthcare providers' access to high-quality information. Their platform connects clinical queries to tailored, evidence-based answers through a network of academic drug information centers. By optimizing this process with machine learning, InpharmD aims to facilitate better-informed decisions in healthcare.
Headquartered in the United States, InpharmD secured a $6.05M Seed Round investment on 07 December 2023 from notable investors including Y Combinator, Atlanta Ventures, 645 Ventures, ELC, and Qlarant Capital. This backing underscores substantial investor confidence in their innovative approach to healthcare.
